Clinical Trial Update: Effect of Actonel on Periodontal Health of Postmenopausal Women [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating Actonel for periodontal health in postmenopausal women has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontal Disease

Drugs mentioned

• Actonel (risedronate)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Periodontal Disease | Phase 4 | Status: WITHDRAWN